Cook Medical’s Zenith Thoraco+ Endovascular System Designated a Breakthrough Device

Cook Medical’s Zenith Thoraco+ endovascular system has been designated a Breakthrough Device by the FDA.

An endovascular graft for thoracoabdominal aortic aneurysm (TAAA) patients, Thoraco+ includes four side branches for the celiac artery, superior mesenteric artery, left renal artery and right renal artery.

The Thoraco+ will be available in a range of diameters and lengths to accommodate varied patient anatomies, the Bloomington, Ind.-based company said.